Frequency of CD39+, LAG3+, and CTLA4+ Regulatory T Cells in Two Different Immunosuppressive Protocols in Renal Allograft Recipients (Sirolimus vs Mycophenolate mofetil): A Cohort Report

CONCLUSIONS: it seems that both treatment regimen protocols with a low dose ATG induction therapy may be clinically applicable in kidney transplant recipients.PMID:36190377 | DOI:10.22034/iji.2022.92623.2161
Source: Iranian Journal of Immunology - Category: Allergy & Immunology Authors: Source Type: research